BioSpace News Archive

Biotech Beach

Amplyx Announces Presentations on APX001 at American Society for Microbiology Microbe 2018 and the 20th Symposium on Infections in the Immunocompromised Host

Amplyx Pharmaceuticals announced that Amplyx and its collaborators will be participating in and presenting at two scientific conferences in the upcoming weeks.

June 7, 2018
·
3 min read
Deals

BrainStorm Announces Exercise of Warrants Resulting in Cash Proceeds of ~$12.3 Million at $5 Share

BrainStorm Cell Therapeutics Inc. announced it has entered into a Warrant Exercise Agreement with certain holders of warrants issued in the January 8, 2015 private placement.

June 7, 2018
·
4 min read
Pharm Country

Westinghouse Awarded $5 Million from U.S. Department of Energy

Westinghouse Electric Company announced today that it was awarded $5 million in funding from the U.S. Department of Energy’s (DOE’s) Advanced Research Projects Agency-Energy (ARPA-E).

June 7, 2018
·
2 min read
Business

Dr. Michele Ross, Leading Cannabis Voice, Joins NanoSphere Health Sciences Team

Dr. Michele Ross has joined the advisory board for NanoSphere Health Sciences, LLC

June 7, 2018
·
5 min read
Biotech Bay

New All-In-One Home Medication Dispensing System Launches With Kickstarter

As Directed Plus LLC (www.asdirectedtlc.com) has launched a Kickstarter Campaign for its innovative smart medication dispensing device.

June 7, 2018
·
3 min read
Body and Mind Obtains Ownership Interest in Ohio Medical Cannabis Dispensary License

Body and Mind Inc. is pleased to announce the Company and its strategic in-state investment partners received notification that the State of Ohio awarded a medical cannabis dispensary license to NMG, Ohio LLC

June 7, 2018
·
6 min read
Pharm Country

PANTHERx® Specialty Pharmacy Selected by Ultragenyx to Distribute Crysvita

Crysvita™ is the very first FDA-approved therapy for children and adults with x-linked hypophosphatemia

June 7, 2018
·
2 min read
VECT-HORUS Raises 3.5 M€ to Accelerate its Development Programs

VECT-HORUS, a biotechnology company that designs and develops vectors facilitating targeting of therapeutic molecules and imaging agents...

June 7, 2018
·
1 min read
Drug Development

CytRx Corporation Highlights NantCell Inc’s Aldoxorubicin Clinical Data Presented at the American Society of Clinical Oncology 2018 Annual Meeting

Data Show Aldoxorubicin, Alone or in Combination with Ifosfamide, Lacks Cardiotoxicity with Doxorubicin Equivalent Doses Beyond 1000 mg/m2

June 7, 2018
·
4 min read
Business

Egalet Appoints Industry Veteran John Varian to Board of Directors

Varian most recently served as the CEO and director of XOMA, an antibody business, where he led the refocusing and refinancing of the company

June 7, 2018
·
5 min read